Clinical research in geriatric patient populations requires the adaptation of traditional clinical procedures in research studies. A relatively new area of research, geriatric patient studies requires a collaboration between many different stakeholders within this field to identify and overcome the challenges involved in recruiting, treating and retaining study subjects. Join SMi as we look to address these issues with new and innovative thinking and approaches that are being applied to geriatric clinical studies.

KEY REASONS TO ATTEND
• Discover the benefits of performing clinical trials in older people
• Identify the key challenges and considerations when conducting clinical trials in older people
• Address reasons for clinical trial retention difficulties
• Discuss how modelling and simulation along with new patient reporting systems support clinical trials in older people
• Explore new market gaps and discover new market strategy
• Focus on the EMA geriatric medicines strategy

KEYNOTE SPEAKERS INCLUDE:
• Solange Rohou, Director of Regulatory Affairs, AstraZeneca
• Barbro Westerholm, Member of Parliament, Sweden, Liberal Party
• Florian Von Raison, Global Programme Head, Novartis
• Nina Barnett, Consultant Pharmacologist, Northwest London's Hospital NHS Trust
• Philippe Guillet, Strategy Head, Sanofi
• Michael Richardson, VP International and QPPV EU GPV&E, Bristol Myers Squibb
• Eva Bredberg, Director Global Clinical Pharmacology, AstraZeneca
• Anthea Tinker, Professor of Social Gerontology, Kings College London

Click here to find out more and/or book your place.